The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for budding threats to Americans’ health, is without a clear leader.

A top expert at the Centers for Disease Control and Prevention who was overseeing the process to update COVID-19 vaccine recommendations resigned on Tuesday. The departing CDC official, Lakshmi ...

Like it or not, COVID-19 is still a public health issue five years after the start of the pandemic flipped the nation, and the world, on its head. Here is a brief recap of the status of COVID ...

Moderna convinced a U.S. appeals court on Wednesday to uphold a ruling that undercut patent infringement claims by biotech company Alnylam Pharmaceuticals over Moderna's blockbuster COVID-19 ...

Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday.

COLUMBUS, Ohio (WCMH) – Scientists were searching for a central Ohio resident with a mysterious strain of COVID-19. Before they could find them, it vanished. Molecular virologist Marc Johnson, a ...

HHS ends free COVID-19 test program, citing waste of taxpayer funds as it shifts focus to chronic disease issues under Trump's Make America Healthy Again initiative.

June 3 (Reuters) - Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos of the U.S. CDC resigned on Tuesday as co-leader of a working group that advises outside experts on COVID-19 ...

SEATTLE — The Washington Department of Health (DOH) said Monday it has detected a new COVID-19 variant in the state. According to the DOH, health officials found 14 sequenced detections of NB.1. ...

BOSTON, Mass. (WKRC) — The family of a man who died after contracting a tick-borne virus has a warning for others. According to PEOPLE, 62-year-old Kevin Boyce of Boston, Massachusetts ...

The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is part ...

The U.S. Food and Drug Administration (FDA) on Saturday approved Moderna, Inc.’s MRNA mNexspike (mRNA-1283), a new vaccine against COVID-19, for all adults 65 and older and individuals aged 12 ...